Search results
Found 7347 matches for
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
Population, Global, and Public Health
Population and global health research generates evidence that reliably answers important questions about human health.